Skip to main content
FOR PAYERS
JOBS
MORE
Video
Podcasts
Events
Newsletters
Sponsored
About
REIMBURSEMENT
REVENUE CYCLE MANAGEMENT
STRATEGIC PLANNING
CAPITAL FINANCE
SUPPLY CHAIN
ACCOUNTING & FINANCIAL MANAGEMENT
MORE
Acute Care
Ambulatory Care
Analytics
HFN @ ANI
Billing and Collections
Budgeting
Business Intelligence
Claims Processing
Community Benefit
Compliance & Legal
Construction & Facilities Management
Hospital/physician relations
ICD-10 & Coding
Meaningful Use
Medical Devices
Medicare & Medicaid
Mergers & Acquisitions
Operations
Patient Engagement
Pharmacy
Policy and Legislation
Population Health
Quality and Safety
Risk Management
Telehealth
Workforce
Marshall Allen and Olga Pierce, Pro Publica
The costly use of unapproved tools
By
Marshall Allen and Olga Pierce, Pro Publica
|
10:14 am |
February 10, 2015
Loose rules by the FDA allowing products that should receive closer scrutiny to slip by.